LUTATHERA

Lutetium Lu-177 dotatate · Advanced Accelerator Applications USA, Inc

Drug timelines are a Plus or Pro feature.

48 regulatory and trial events tracked for LUTATHERA, covering 2018-01-26 to 2026-08-14. Get the full timeline:

Most recent: EMA Authorised: Lutathera (lutetium (177Lu) oxodotreotide) — Novartis Europharm Limited